Paper42957232PubMed
Complete Response Demonstrated by [11C]methionine-PET Imaging of a Patient With Squamous-cell Carcinoma of the Tongue Treated With Chemotherapy, Immunotherapy and Methionine Restriction Without Radiation or Surgery: A Potential New Low-toxicity Treatment Paradigm for a Recalcitrant Disease.
Ishiguro T and 8 others. In Vivo, 2026.
Cite this record
ConductScience Library. Complete Response Demonstrated by [11C]methionine-PET Imaging of a Patient With Squamous-cell Carcinoma of the Tongue Treated With Chemotherapy, Immunotherapy and Methionine Restriction Without Radiation or Surgery: A Potential New Low-toxicity Treatment Paradigm for a Recalcitrant Disease. Papers, record 42957232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42957232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Complete Response Demonstrated by [11C]methionine-PET Imaging of a Patient With Squamous-cell Carcinoma of the Tongue Treated With Chemotherapy, Immunotherapy and Methionine Restriction Without Radiation or Surgery: A Potential New Low-toxicity Treatment Paradigm for a Recalcitrant Disease.
- Journal
- In Vivo
- Year
- 2026
- Publication types
- Journal Article, Case Reports
- Revised in PubMed
- 2026-11-03
Source PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Methionine | Major topic |
| Tongue Neoplasms | Major topic |
| Carcinoma, Squamous Cell | Major topic |
| Positron-Emission Tomography | Major topic |
| Humans | |
| Middle Aged | |
| Male | |
| Immunotherapy | |
| Treatment Outcome | |
| Pathologic Complete Response | |
| Antineoplastic Combined Chemotherapy Protocols | |
| Combined Modality Therapy |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 42746398 | Direct comparison of serine restriction on the viability of normal and cancer cells demonstrates that methionine restriction is more cancer specific. | Front Oncol | 2026 | https://conductscience.org/library/papers/42746398 | PubMed |
| 2 | 32276408 | Methionine Dependence of Cancer. | Biomolecules | 2020 | https://conductscience.org/library/papers/32276408 | PubMed |
| 3 | 42078309 | Chemotherapy in Combination With Methionine Restriction Induced A Complete Response in a Patient With Recurrent Metastatic Tongue Squamous-Cell Carcinoma. | Cancer Diagn Progn | 2026 | https://conductscience.org/library/papers/42078309 | PubMed |
| 4 | 37367741 | Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma. | Med Sci (Basel) | 2023 | https://conductscience.org/library/papers/37367741 | PubMed |
| 5 | 38522008 | Developments and future prospects of personalized medicine in head and neck squamous cell carcinoma diagnoses and treatments. | Cancer Rep (Hoboken) | 2024 | https://conductscience.org/library/papers/38522008 | PubMed |
| 6 | 6261250 | Reversible growth arrest in simian virus 40-transformed human fibroblasts. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6261250 | PubMed |
| 7 | 22677908 | Dietary methyl donor depletion protects against intestinal tumorigenesis in Apc(Min/+) mice. | Cancer Prev Res (Phila) | 2012 | https://conductscience.org/library/papers/22677908 | PubMed |
| 8 | 13638009 | Quantitative nutritional studies with water-soluble, chemically defined diets. VIII. The forced feeding of diets each lacking in one essential amino acid. | Arch Biochem Biophys | 1959 | https://conductscience.org/library/papers/13638009 | PubMed |
| 9 | 5230235 | Methylation of nucleic acids in normal and leukemic leukocytes. | Biochim Biophys Acta | 1966 | https://conductscience.org/library/papers/5230235 | PubMed |
| 10 | 29928962 | Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer. | Cancer Lett | 2018 | https://conductscience.org/library/papers/29928962 | PubMed |
| 11 | 41318119 | FDG- and MET-PET Imaging Reveal Glucose and Methionine Addiction in a Primary Endometrial Cancer and Methionine Addiction only in a Para-aortic Lymph-node Metastasis in a 58-year-old Patient. | Anticancer Res | 2025 | https://conductscience.org/library/papers/41318119 | PubMed |
| 12 | 6661235 | The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. | Biochem Biophys Res Commun | 1983 | https://conductscience.org/library/papers/6661235 | PubMed |
| 13 | 6937240 | Effect of nutritional and enzymatic methionine deprivation upon human normal and malignant cells in tissue culture. | Cancer Res | 1980 | https://conductscience.org/library/papers/6937240 | PubMed |
| 14 | 36768257 | Superiority of [11C]methionine over [18F]deoxyglucose for PET Imaging of Multiple Cancer Types Due to the Methionine Addiction of Cancer. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36768257 | PubMed |
| 15 | 6500606 | Elevated overall rates of transmethylation in cell lines from diverse human tumors. | In Vitro | 1984 | https://conductscience.org/library/papers/6500606 | PubMed |
| 16 | 3457200 | Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect. | J Natl Cancer Inst | 1986 | https://conductscience.org/library/papers/3457200 | PubMed |
| 17 | 35434545 | Linkage of methionine addiction, histone lysine hypermethylation, and malignancy. | iScience | 2022 | https://conductscience.org/library/papers/35434545 | PubMed |
| 18 | 41438985 | Human fibrosarcoma cells selected for ultra-high doxorubicin resistance, acquire trabectedin cross-resistance, remain sensitive to recombinant methioninase, and have increased c-MYC expression. | Front Oncol | 2025 | https://conductscience.org/library/papers/41438985 | PubMed |
| 19 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 20 | 2213904 | Methionine dependency of malignant tumors: a possible approach for therapy. | J Natl Cancer Inst | 1990 | https://conductscience.org/library/papers/2213904 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42957232
GET https://conductscience.org/api/papers/v1/42957232/references?page=2